Larvol Delta - Cerecor-Announces-First-Patient-Dosed-in-a-Phase-1b-Clinical-Trial-of-CERC007-for-the-Treatment-of-Relapsed-or-Refractory-Multiple-Myeloma

CERC-007 - Cerecor

https://www.globenewswire.com/news-release/2020/12/16/2146035/0/en/Cerecor-Announces-First-Patient-Dosed-in-a-Phase-1b-Clinical-Trial-of-CERC-007-for-the-Treatment-of-Relapsed-or-Refractory-Multiple-Myeloma.html

Dec 16, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next